BioSpace News Archive

Business

Endologix Reports Second Quarter 2019 Financial Results

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced financial results for the second quarter ended June 30, 2019.

August 8, 2019
·
9 min read
Policy

Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial

Targeting Topline Data from STRIDE 3 by the End of 2019

August 8, 2019
·
6 min read
Deals

Pulse Biosciences Quarterly Investor Conference Call - Aug. 8, 2019

Pulse Biosciences, Inc. reported recent corporate developments and financial results for the three- and six-month periods ended June 30, 2019.

August 8, 2019
·
7 min read
Business

Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial Results

Announced Clinical Trial Agreement with Washington University School of Medicine to Conduct a Phase 1b/2a Clinical Trial of SYN-004 in Allogeneic Hematopoietic Cell Transplant Recipients

August 8, 2019
·
14 min read
Business

Trovagene Announces Second Quarter 2019 Results and Highlights

The company is issuing this press release in lieu of conducting a conference call.

August 8, 2019
·
14 min read
Business

Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market

The long-term agreement includes distribution rights to Endologix’s current EndoVascular Aneurysm Repair and Endovascular Aneurysm Sealing products, as well as the right of first negotiation for future product offerings by Endologix.

August 8, 2019
·
4 min read
Business

Dicerna™ Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Strengthened Management with Senior Hires Across Medical Affairs, Commercial, Regulatory, and Patient Advocacy and Patient Services

August 8, 2019
·
12 min read
Business

Myomo Reports Second Quarter 2019 Results

Record Quarterly Revenues and 28% Sequential Expansion of Reimbursement Pipeline

August 8, 2019
·
12 min read
Business

Tricida Announces Second Quarter 2019 Financial Results

Narrows Timing of Planned NDA Submission to the Third Quarter of 2019

August 8, 2019
·
10 min read
Business

BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update

Announced Rebranding and Name Change to Lineage Cell Therapeutics and Corporate Relocation

August 8, 2019
·
19 min read